부산대학교 도서관

Langmann, S.; Schwarzfischer, L.; Li, J.; Skidgel, R. A.; Andreesen, R.; Krause, S. W.; Rehli, M.

Onkologie. Oct 01, 2002 25 Suppl 4:187-187

Heid, Iris M.; Rehli, Michael; Kronenberg, Florian

Public Health Forum. 19(2):10-12

Baldwin J. G.; Heuser-Loy C.; Saha T.; Schelker R.; Slavkovic-Lukic D.; Strieder N.; Hernandez-Lopez I.; Rana N.; Barden M.; Mastrogiovanni F.; Martin-Santos A.; Raimondi A.; Brohawn P.; Higgs B. W.; Gebhard C.; Kapoor V.; Telford W. G.; Gautam S.; Xydia M.; Beckhove P.; Frischholz S.; Schober K.; Kontarakis Z.; Corn J. E.; Iannacone M.; Inverso D.; Rehli M.; Fioravanti J.; Sengupta S.; Gattinoni L.

Cell. 187:6614-6630.e21

Forrest, ARR; Kawaji, H; Rehli, M; Baillie, JK; de, Hoon MJL; Haberle, V; Lassmann, T; Kulakovskiy, IV; Lizio, M; Itoh, M

NATURE. 507(7493):462-470

Pohl, S.; Heudobler, D.; Loyola, V. Bengt Pastor; Gebhard, C.; Mossner, M.; Jann, J.C.; Hirabayashi, S.; Nowak, D.; Wlodarski, M.; Hofmann, W.K.; Niemeyer, C.; Rehli, M.

Leukemia Research. 55:S92-S92

Fischer JC; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany. julius.fischer@tum.de.; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. julius.fischer@tum.de.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France. julius.fischer@tum.de.; Göttert S; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Giller M; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Heinrich P; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Fan K; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Khalid O; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Walther CN; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Department of Nephrology, Technical University Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Drießlein M; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Nefzger SM; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Eisenkolb G; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Department of Gynecology and Obstetrics, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Timnik VR; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Jarosch S; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany.; Klostermeier L; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Engleitner T; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute of Molecular Oncology and Functional Genomics, Munich, Germany.; Strieder N; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Gebhard C; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Diederich S; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Schmid NA; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Lansink Rotgerink L; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Joachim L; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Ghimire S; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Vonbrunn E; Department of Nephropathology, Institute of Pathology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Büttner-Herold M; Department of Nephropathology, Institute of Pathology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Remke M; Technical University of Munich (TUM), TUM School of Medicine and Health, Comparative Experimental Pathology, Munich, Germany.; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute of Pathology, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Steiger K; Technical University of Munich (TUM), TUM School of Medicine and Health, Comparative Experimental Pathology, Munich, Germany.; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute of Pathology, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Öllinger R; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute of Molecular Oncology and Functional Genomics, Munich, Germany.; Rad R; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute of Molecular Oncology and Functional Genomics, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Department of Medicine II, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Wolff D; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Feuerer M; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Hoffmann P; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Edinger M; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Rehli M; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Tschurtschenthaler M; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, TUM University Hospital, Chair of Translational Cancer Research and Institute of Experimental Cancer Therapy, Munich, Germany.; Kepp O; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France.; Kroemer G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France.; Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, France-HP, Paris, France.; Thiele Orberg E; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Herr W; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Bassermann F; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, A partnership between DKFZ and TUM University Hospital, Munich, Germany.; Bavarian Cancer Research Centre (BZKF), Munich, Germany.; Busch DH; Technical University of Munich (TUM), TUM School of Medicine and Health, Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany.; Holler E; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany.; Heidegger S; Department for Internal Medicine III, Technical University of Munich (TUM), TUM School of Medicine and Health, TUM University Hospital, Munich, Germany.; Technical University of Munich, TUM School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), Munich, Germany.; Poeck H; University Hospital Regensburg, Department for Internal Medicine III, Hematology & Oncology, Regensburg, Germany. hendrik.poeck@ukr.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. hendrik.poeck@ukr.de.; Bavarian Cancer Research Centre (BZKF), Regensburg, Germany. hendrik.poeck@ukr.de.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Dutruel, C.; Bergmann, F.; Rooman, I.; Zucknick, M.; Weichenhan, D.; Geiselhart, L.; Kaffenberger, T.; Rachakonda, P.S.; Bauer, A.; Giese, N.; Hong, C.; Xie, H.; Costello, J.F.; Hoheisel, J.; Kumar, R.; Rehli, M.; Schirmacher, P.; Werner, J.; Plass, C.; Popanda, O.; Schmezer, P.

Oncogene. June 26, 2014, Vol. 33 Issue 26, p3401, 10 p.

Mena Report. March 12, 2024

Mena Report. March 11, 2024

Göttert S; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Thiele Orberg E; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany. erik.orberg@ukr.de.; Fan K; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Heinrich P; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Matthe DM; Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.; Khalid O; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Klostermeier L; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Suriano C; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Strieder N; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Gebhard C; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Vonbrunn E; Department of Nephropathology, Institute of Pathology, Universitätsklinikum Erlangenm, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Mamilos A; Institut of Pathology, University of Regensburg, Regensburg, Germany.; Department of Pathology, German Oncology Center, Limassol, Cyprus.; Hirsch D; Institut of Pathology, University of Regensburg, Regensburg, Germany.; Meedt E; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Kleigrewe K; Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Freising, Germany.; Hiergeist A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Schwarz A; Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; Gläsner J; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Ghimire S; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Joachim L; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Voll F; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Neuhaus K; ZIEL - Institute for Food & Health-, Technische Universität München, Freising, Germany.; Janssen KP; Department of Surgery, TUM School of Medicine and Health, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; Perl M; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Pielmeier F; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Ruland J; German Cancer Consortium (DKTK), partner-site Munich, a partnership between DKFZ and Klinikum rechts der Isar, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Kreutz M; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Weber D; Institut of Pathology, University of Regensburg, Regensburg, Germany.; Schmidl C; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Köhler N; Department of Internal Medicine I, Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany.; Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany.; Tschurtschenthaler M; Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Chair of Translational Cancer Research and Institute of Experimental Cancer Therapy, TUM School of Medicine and Health, Klinikum rechts der Isar at Technical University of Munich, Munich, Germany.; Hoffmann P; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Edinger M; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Wolff D; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Bassermann F; Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; German Cancer Consortium (DKTK), partner-site Munich, a partnership between DKFZ and Klinikum rechts der Isar, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Rehli M; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.; Haller D; ZIEL - Institute for Food & Health-, Technische Universität München, Freising, Germany.; Chair of Nutrition and Immunology, Technische Universität München, Freising, Germany.; Evert M; Institut of Pathology, University of Regensburg, Regensburg, Germany.; Hildner K; Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.; Büttner-Herold M; Department of Nephropathology, Institute of Pathology, Universitätsklinikum Erlangenm, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Herr W; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Gessner A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Heidegger S; Department of Internal Medicine III, School of Medicine and Health, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany.; Holler E; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany.; Poeck H; Department of Internal Medicine III, Hematology & Internal Oncology, University Hospital Regensburg, Regensburg, Germany. hendrik.poeck@ukr.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. hendrik.poeck@ukr.de.; Bavarian Cancer Research Center (BZKF), Munich, Germany. hendrik.poeck@ukr.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Pohl, S.; Heudobler, D.; Gebhard, C.; Hirabayashi, S.; Niemeyer, C.; Wlodarski, M.; Rehli, M.

Leukemia Research. 37:S20-S21

Mena Report. February 15, 2024

Mena Report. June 29, 2023

Mena Report. April 20, 2023

Mena Report. April 11, 2023

Mena Report. April 15, 2023

Beumer, N.; Imbusch, C.D.; Kaufmann, T.; Braband, K.L.; Voss, M.M.; Helbich, S.S.; Mihoc, D.M.; Delacher, M.; Marini, F.; Simon, M.; Brors, B.; Schmidleithner, L.; Gütter, K.; Stüve, P.; Marchel, H.; Ruhland, B.; Sanderink, L.; Ritter, U.; Gebhard, C.; Rehli, M.; Strieder, N.; Schmidl, C.; Hehlgans, T.; Feuerer, M.; Weichenhan, D.; Bähr, M.; Plass, C.; Hotz-Wagenblatt, A.; Nassabi, H.; Eigenberger, A.; Prantl, L.; Singh, K.; Huehn, J.; Polansky, J.K.

In: Nature Immunology. (Nature Immunology, August 2025, 26(8):1315-1328)

Habenicht, K.M.; Wanzek, J.; Bootz, A.; Schäfer, S.; Vollmer, L.; Hasenbank, J.; Schneider, A.; Winkler, T.H.; Vasova, I.; Spoerl, S.; Brandt, A.; Mackensen, A.; Winkler, J.; Hiergeist, A.; Gessner, A.; Fante, M.; Rehli, M.; Hoffmann, P.; Wolff, D.; Wirtz, S.; Kotorri, J.; Gerlach, R.G.

In: Blood. (Blood, 26 June 2025, 145(26):3178-3188)

Mena Report. September 2, 2020

Mena Report. July 9, 2019